Zadaxin thymosin alpha I in combination with alpha interferon data

An abstract reporting results of a U.S. Phase III trial of Zadaxin was published in Hepatology, showing a statistically significant difference in efficacy in chronic hepatitis C patients treated with a combination of Zadaxin and alpha interferon versus either interferon alone or placebo. Details will be presented at the meeting of the American Association for the Study of Liver Diseases in November. ...